|
|
Volumn 22, Issue 5, 2000, Pages 599-607
|
|
Comparison of the pharmacokinetics and in vivo bioaffinity of DigiTAb versus Digibind
a
a
b,c
|
|
Author keywords
Digibind; DigiTAb; Digoxin; Pharmacokinetics Digoxin immune Fab
|
|
Indexed keywords
DIGITALIS;
DIGOXIN;
DIGOXIN ANTIBODY F(AB) FRAGMENT;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
BINDING AFFINITY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIGOXIN BLOOD LEVEL;
DRUG BINDING;
DRUG CLEARANCE;
DRUG DETERMINATION;
DRUG DISPOSITION;
DRUG DISTRIBUTION;
DRUG ELIMINATION;
DRUG HALF LIFE;
FEMALE;
HUMAN;
MALE;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ADULT;
ANTI-ARRHYTHMIA AGENTS;
AREA UNDER CURVE;
CHEMISTRY, PHARMACEUTICAL;
DIGOXIN;
FEMALE;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
INFUSIONS, INTRAVENOUS;
MALE;
REFERENCE VALUES;
|
|
EID: 0033806680
PISSN: 01634356
EISSN: None
Source Type: Journal
DOI: 10.1097/00007691-200010000-00016 Document Type: Article |
|
Times cited : (19)
|
|
References (14)
|
